Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

383results about How to "High drug loading" patented technology

Soaking solution for corneal contact lens, preparation method and corneal contact lens

The invention provides a soak solution for a corneal contact lens, a preparation method of the soak solution and the corneal contact lens, and the soak solution is mainly prepared from the following raw materials in percentage by mass: 0.01%-0.15% of litamilast, 0.01%-0.15% of sodium dodecyl benzene sulfonate, 0.01%-0.15% of sodium dodecyl benzene sulfonate and the balance of water. 0.1%-2% of buffer salt; 0.2%-1.2% of sodium chloride; 0-0.5% of sodium thiosulfate; and 97%-99% of purified water. The soak solution for the corneal contact lens prepared by the invention can well interact with water molecules in the corneal contact lens, so that drug molecules in the soak solution are well replaced in the corneal contact lens, and the drug molecules are retained in a gel network of the corneal contact lens; the bioavailability of the medicine is improved while high medicine loading capacity is realized, and the corneal contact lens prepared from the soak solution has the effect of slowly releasing the medicine, directly acts on eyes and can reduce the toxic and side effects of the medicine.
Owner:SHANGHAI MODERN PHARMACEUTICAL ENGINEERING RESEARCH CENTER CO LTD

Nuclide nano hydrogel microneedle as well as preparation method and application thereof

The invention provides a nuclide nano hydrogel microneedle and a preparation method and application thereof, and belongs to the field of nano biological medicines.The nuclide nano hydrogel microneedle comprises a needle tip layer and a substrate layer, the needle tip layer is formed by loading a nuclide nano-drug to a methacrylated gelatin microneedle tip, the nuclide nano-drug comprises Ag2S nanoparticles and radionuclide 32P labeled calcium phosphate, and the substrate layer is formed by loading the nuclide nano-drug to the methacrylated gelatin microneedle tip. Ag2S and Ca32P nanoparticles are formed through a biological mineralization reaction, and a substrate layer is a substrate matrix and comprises hyaluronic acid; ag2S and Ca32P in the nuclide nano-drug hydrogel microneedle prepared by the scheme can respond to a weak acid environment of tumors to release Ag2S nanoparticles, under the irradiation of near-infrared light, the photothermal conversion efficiency of the Ag2S nanoparticles can effectively kill bacteria, meanwhile, the low-oxygen environment of the tumors is effectively improved, the treatment effect of nuclides is enhanced, and the nuclide nano-drug hydrogel microneedle has a good application prospect. The antibacterial and wound healing promoting effects are achieved in melanoma defect repair, and tumor growth and tumor recurrence can be inhibited to the maximum extent.
Owner:XIANGYA HOSPITAL CENT SOUTH UNIV

Targeted drug delivery carrier based on mesoporous polydopamine nanoparticles and application

The invention relates to a targeted drug delivery carrier based on mesoporous polydopamine nanoparticles and application thereof.The targeted drug delivery carrier is galactose modified mesoporous dopamine coordinated with manganese ions, lysine is adopted in the carrier synthesis step to provide an alkaline environment needed by dopamine polymerization, the polymerization process is simplified, and the drug delivery efficiency is improved. Meanwhile, lysine can be introduced into the mesoporous polydopamine; and the drug loading capacity of the carrier is improved. The carrier gathers multifunctionality of drug delivery, tumor imaging and treatment, provides a comprehensive new method for tumor treatment, and enhances individuation and precision of treatment.
Owner:BEOGENE BIOTECH GUANGZHOU

Preparation method and application of magnesium L-threonate

The invention provides a preparation method and application of magnesium L-threonate, and belongs to the technical field of medicines. The preparation method comprises the following steps: dissolving L-ascorbic acid in water, adding magnesium hydroxide and alkaline magnesium carbonate, stirring, dropwise adding hydrogen peroxide, heating, stirring and reacting, filtering a product, purifying and concentrating by temperature-sensitive molecularly imprinted hydrogel while the product is hot, adding an ethanol water solution into a concentrated solution, standing, crystallizing, filtering, washing and drying to obtain the magnesium L-threonate. And cooling the temperature-sensitive molecularly imprinted hydrogel after adsorption to room temperature, washing and repeatedly using the temperature-sensitive molecularly imprinted hydrogel. The magnesium L-threonate is simple in preparation method, high in purity and high in yield, meanwhile, the slow-release magnesium L-threonate is prepared, and the magnesium L-threonate is low in toxicity, good in biocompatibility, large in drug loading capacity, low in economic cost and good in drug effect and has wide application prospects in preparation of anti-depression drugs.
Owner:SUZHOU MYLAND PHARM & NUTRITION INC

Mulberry leaf extract multivesicular liposome, preparation method, health food and hypoglycemic application of mulberry leaf extract multivesicular liposome

The invention relates to the technical field of food health care, in particular to mulberry leaf extract multivesicular liposome, a preparation method, health care food and hypoglycemic application of the mulberry leaf extract multivesicular liposome. The mulberry leaf extract multivesicular liposome comprises a mulberry leaf extract and a blank multivesicular liposome, the mulberry leaf extract contains mulberry leaf flavone and mulberry leaf alkaloid; the blank multivesicular liposome is composed of lipid bilayers, and the interior of the blank multivesicular liposome comprises a plurality of water-based chambers which are separated by the lipid bilayers; wherein the mulberry leaf flavone is located between lipid bilayers, and the mulberry leaf alkaloid is located in the water-based chamber. According to the mulberry leaf extract multivesicular liposome provided by the invention, embedding of mulberry leaf flavone and mulberry leaf alkaloid can be realized at the same time, so that the effect of reducing blood sugar is better achieved.
Owner:XIAN NUOZHONGKANGJIAN BIOTECHNOLOGY CO LTD

High-stability doxorubicin liposome injection preparation and preparation process thereof

The invention relates to the technical field of liposome preparations, in particular to a high-stability doxorubicin liposome injection preparation and a preparation process thereof. Comprising the following steps: S1, preparing doxorubicin liposome; S11, preparing distearoyl phosphatidyl ethanolamine-polyethylene glycol-tocopherol; s12, hydrogenated lecithin, distearoyl phosphatidyl ethanolamine-polyethylene glycol-tocopherol, cholesterol, absolute ethyl alcohol and ammonium sulfate are sheared, mixed and filtered, and a blank liposome crude product is obtained; s13, carrying out dialysis treatment on the blank liposome crude product to obtain a blank liposome suspension; s14, adding a doxorubicin solution into the blank liposome suspension, heating and preserving heat, and then performing sterilization treatment and reduced-pressure rotary evaporation to obtain doxorubicin lipid; and S2, preparing the doxorubicin liposome and the compound water for injection into a high-stability doxorubicin liposome injection preparation, and storing for later use.
Owner:CHANGZHOU JINYUAN PHARM MFG CO LTD

Dimethylcurcumin liposome as well as preparation method and application thereof

The invention provides a dimethyl curcumin liposome, which is prepared from dimethyl curcumin, phospholipid, cholesterol and a freeze-drying protective agent as raw materials, has the advantages of small particle size, high drug loading capacity and excellent freeze-drying redissolution performance, and effectively overcomes the problems of poor water solubility and low bioavailability of the dimethyl curcumin. Moreover, according to the preparation method of the dimethyl curcumin liposome provided by the embodiment of the invention, the dimethyl curcumin liposome is prepared by adopting a film dispersion method, the dimethyl curcumin can be encapsulated in the liposome, the water solubility of the dimethyl curcumin can be improved, the particle size of the dimethyl curcumin liposome is relatively small, and the water solubility of the dimethyl curcumin can be improved. The compound is easily taken by tumor cells, and the targeting effect and the killing effect on the tumor cells are enhanced. In addition, the lipidosome of dimethyl curcumin in the invention has a slow release effect, and can enhance cellular uptake. An in-vitro tumor suppression research shows that the liposome loaded with the free dimethyl curcumin has a relatively strong killing effect on tumor cells.
Owner:CHANGZHOU UNIV

Albendazole nanocrystal with high bioavailability and preparation method thereof

The invention discloses an albendazole nanocrystal with high bioavailability and a preparation method of the albendazole nanocrystal. The nanocrystal is prepared by mixing albendazole, a natural glycoside stabilizer and water to form a suspension and grinding the suspension by adopting a wet medium, the average particle size is 100 to 500 nm. The nanocrystal is obtained by dispersing albendazole in a natural source glycoside solution and performing nanocrystallization treatment, the drug loading capacity is high, and the solubility and dissolution rate of albendazole can be greatly improved, so that the absorption of albendazole is improved, and the bioavailability of albendazole is improved. The stabilizer adopted by the invention is rich in resource, natural and economical, the preparation process is simple, efficient and safe, and is suitable for industrial production, and an intermediate with high bioavailability is provided for an albendazole preparation.
Owner:CHINA PHARM UNIV

Curcumin-loaded brain-targeted drug delivery system as well as preparation method and application thereof

PendingCN119587703Areserved functionStrong targetingNervous disorderSolution deliveryCerebral paralysisCyclodextrin
The invention discloses a curcumin-loaded brain-targeted drug delivery system as well as a preparation method and application thereof. The delivery system comprises a carrier macrophage and a curcumin drug, the curcumin nano-drug is prepared by encapsulating curcumin with a lipoic acid modified cyclodextrin conjugate, then macrophages and the curcumin nano-drug are mixed, and co-incubation is carried out, so that the curcumin nano-drug is constructed. The brain-targeted macrophage drug delivery system loaded with curcumin is a multifunctional composite drug with brain targeting property for treatment of cerebral arterial thrombosis. A brain-targeted macrophage drug delivery system loaded with the curcumin nano-drug gathers in cerebral apoplexy tissues, phenotypic transformation of inflammatory microglial cells is promoted, and a pro-inflammatory microenvironment is improved; the oxidative stress pressure of the stroke part is improved; the two effects promote each other, the stroke microenvironment is improved, the functions of neuronal cells are saved, the synergistic nerve protection effect can be achieved in the aspect of treating ischemic cerebral apoplexy, and potential safety hazards are reduced.
Owner:INST OF BIOMEDICAL ENG CHINESE ACAD OF MEDICAL SCI

Dacron large biological fiber containing rose active component and preparation method of polyester large biological fiber

The invention provides a large polyester bio-fiber containing rose active ingredients and a preparation method of the large polyester bio-fiber. The large polyester bio-fiber comprises the following raw materials in parts by weight: 10-12 parts of polyester chips and 2-3 parts of rose extract microcapsules, the preparation method of the rose extract microcapsule comprises the following steps: adding tannic acid into a sodium alginate aqueous solution, stirring and mixing to obtain a solution A, adding nano-hydroxyapatite, a calcium chloride / glutaraldehyde composite cross-linking agent, a rose extract and lauryl sodium sulfate into a chitosan acetic acid aqueous solution, stirring and mixing to obtain a solution B, and uniformly stirring to obtain the rose extract microcapsule. And mixing and stirring the solution A and the solution B to obtain the rose extract microcapsule. According to the polyester large biological fiber containing the rose active component and the preparation method of the polyester large biological fiber, the rose active component is effectively and uniformly introduced into the polyester fiber, meanwhile, the original physical performance of the fiber is kept, the stability of the active component is further kept, the slow release time is prolonged, and the polyester large biological fiber is endowed with more health functions.
Owner:BAICAO FUTURE HEALTH TECHNOLOGY (QINGDAO) CO LTD +1

Preparation and application of soluble oligodeoxyribonucleotide microneedle for whitening and removing freckles

The invention provides an active composition. The active composition is prepared from the following components in parts by weight: 0.1 to 2 parts of oligodeoxyribonucleotide, 0.01 to 1 part of Decapeptide-12, 0.005 to 0.5 part of isolopeicoside, 0.1 to 10 parts of L-cysteine and 0.05 to 5 parts of cyclo (proline-tyrosine). According to the invention, the active composition is prepared into hydrogel microspheres, and then the hydrogel microspheres are combined with the microneedle matrix to prepare the whitening and freckle-removing soluble slow-release microneedle patch with high drug loading capacity, and the microneedle patch has very good effects of whitening skin, fading / removing color spots and slowly releasing.
Owner:TIANJIN SAIMENG BIOTECHNOLOGY CO LTD +2

Cinnamaldehyde self-emulsifying nanoemulsion as well as preparation method and application thereof

PendingCN119015268AHigh drug loadingBreaking through the limitations of antibacterial applicationsBiocideAntibacterial agentsBiofilmDistilled water
The invention discloses cinnamyl aldehyde self-emulsifying nanoemulsion as well as a preparation method and application thereof. The nanoemulsion comprises the following components in percentage by weight: 5-10% of an oil phase, 30-40% of an emulsifier, 15-20% of a co-emulsifier, 5-10% of cinnamyl aldehyde and 20-40% of distilled water. The cinnamyl aldehyde nano-emulsion is prepared by adopting a self-emulsifying method in a low-energy emulsifying method, the preparation method is simple and easier to put into production operation, the drug loading capacity of the nano-emulsion is improved, the energy consumption for preparation is reduced, the preparation efficiency is improved, and the antibacterial application limitation of cinnamyl aldehyde is broken through. The cinnamyl aldehyde nanoemulsion prepared by the method has an average particle size of (14.29 + / -0.16) nm, and has good stability under common conditions. Compared with cinnamyl aldehyde raw medicine, the cinnamyl aldehyde compound has good antibacterial activity and an effect of removing MRSA biofilms.
Owner:SICHUAN AGRI UNIV

Camptothecin prodrug as well as drug-loading liposome and application thereof

The invention provides a camptothecin prodrug. The camptothecin prodrug provided by the invention has higher drug retention in the liposome and better stability, and the prodrug liposome can maintain long-time plasma concentration in plasma. In-vitro characterization of the camptothecin prodrug liposome shows that the camptothecin prodrug liposome has higher encapsulation efficiency, drug loading capacity and stability, and can achieve a slow release effect in plasma; the experimental result on the cellular level shows that the compound has higher cellular uptake rate; in-vivo experiments prove that the compound has a better tumor accumulation effect and antitumor activity, can tolerate a higher dosage, and has higher biological safety.
Owner:CHONGQING MEDICAL UNIVERSITY

Epigallocatechin gallate starch nanoparticles as well as preparation method and application thereof

The invention discloses epigallocatechin gallate starch nanoparticles as well as a preparation method and application thereof, and belongs to the technical field of medicinal chemistry. According to the method, high-proportion branched-chain cassava starch is used as a raw material, ultrasonic microwave assistance is adopted, in the nanometer starch alcohol precipitation process, epigallocatechin gallate is synchronously packaged to form nanometer-level epigallocatechin gallate starch nanometer particles, and embedding of epigallocatechin gallate is completed. The embedding rate of the epigallocatechin gallate starch nanoparticles can reach 50.20%, the drug loading capacity can reach 311mg / g, the drug slow release performance is obvious in the process of simulating gastrointestinal digestion, the sustained release time can be 20 hours, the drug release capacity can reach 72.33% and 90.10% respectively, and the preparation process is simple, easy to operate, low in preparation cost and suitable for large-scale production and application.
Owner:GUANGXI UNIV FOR NATITIES

Hyperbranched hemicellulose polymer as well as preparation method and application thereof

The invention relates to the technical field of organic polymer materials, and discloses a hyperbranched hemicellulose polymer as well as a preparation method and application thereof. The hyperbranched hemicellulose polymer provided by the invention has a structural formula as shown in a formula I, and the degree of substitution is 0.58-0.80. The invention provides a method for preparing hyperbranched hemicellulose-based hydrogel by taking hemicellulose extracted from waste liquid as a raw material to synthesize a hyperbranched hemicellulose polymer and taking the hyperbranched hemicellulose polymer as a skeleton. The preparation method provided by the invention has the advantages of simple process, abundant raw material sources, low price, greenness, environmental protection and the like. The prepared hyperbranched hemicellulose-based hydrogel is not only biodegradable, but also has good biocompatibility and water solubility. The hyperbranched hemicellulose hydrogel drug-loading system has good swelling reversibility, pH responsiveness and temperature responsiveness, the selection range of loaded drugs is wide, and the hyperbranched hemicellulose hydrogel drug-loading system has wide application potential.
Owner:HEBEI UNIV OF SCI & TECH

Small molecule gelling agent-borneol assembly

The invention discloses a micromolecular gelling agent-borneol assembly, which is prepared by the following steps: adding micromolecular gelling agent and borneol into petroleum ether according to a mass ratio of 1: (1-3), heating under a closed condition until the micromolecular gelling agent and the borneol are completely dissolved, standing at 0-5 DEG C for 1-4 hours until gel is formed, pre-freezing at-25--15 DEG C for 4-6 hours, and carrying out vacuum freeze drying to obtain the micromolecular gelling agent-borneol assembly. Wherein the structural formula of the micromolecular gelling agent is # imgabs0 #, wherein R1 represents n-octadecyl; and R2 represents-H,-F,-OH,-CH3 or-OCH3. The micromolecular gelling agent-borneol assembly provided by the invention is simple in preparation method and low in dosage of the micromolecular gelling agent, effectively reduces the loss of borneol, and has a good application prospect in a borneol-containing solid preparation.
Owner:SHAANXI UNIV OF CHINESE MEDICINE +1

Water-in-oil nanoemulsion with high drug loading capacity as well as preparation method and application thereof

The invention relates to a water-in-oil nanoemulsion with high drug loading capacity as well as a preparation method and application of the water-in-oil nanoemulsion. The water-in-oil nanoemulsion is prepared by dropwise adding a water-phase solution containing tocoxolam into an oil-phase solution, the water-phase solution is prepared from tocopherol, a cosurfactant, a hydrophilic active matter, a preservative and water; the oil phase solution is composed of liquid grease and a surfactant; the water-in-oil nanoemulsion is prepared from the following components in percentage by mass: 50 to 64 percent of liquid grease, 10 to 17 percent of surfactant, 5 to 8 percent of tocoxolam, 5 to 12 percent of surfactant, 0.1 to 6 percent of hydrophilic active matter, 0.2 to 0.6 percent of preservative and 8 to 15 percent of water. The water-in-oil nanoemulsion has the advantages of high drug loading capacity, good skin permeability, high retention volume in skin cells, high bioavailability, good stability, high safety and the like, and can be used in pure oil cosmetics.
Owner:GUANGZHOU CONGEN PHARMATEC CO LTD

Oxygen-enhanced fluorinated nano assembly for bidirectional amplification of tumor ferroptosis as well as preparation method and application of oxygen-enhanced fluorinated nano assembly

The invention discloses an oxygen-enhanced fluorinated nano assembly for bidirectional amplification of tumor ferroptosis as well as a preparation method and application of the oxygen-enhanced fluorinated nano assembly, and belongs to the technical field of pharmaceutical preparation combined treatment of new auxiliary materials and new dosage forms. According to the invention, the oxygen-functionalized fluorinated adriamycin prodrug with oxygen carrying capacity is designed and synthesized for the first time, a hybrid nano-assembly composed of the disulfide-bridged fluorinated adriamycin prodrug and the ferroptosis inducer is constructed and can be used for tumor treatment, and a fluorinated functional side chain can efficiently carry oxygen to break tumor hypoxia trapping and relieve limitation of hypoxia on Sor, so that the drug can be applied to tumor treatment. DOX can activate NOXs and promote generation of ROS through supplemented oxygen as a catalytic substrate, redox balance is broken through in a two-way synergistic mode, excessive accumulation of lipid peroxide is caused, and therefore the ferroptosis treatment effect is enhanced, a new strategy and more choices are provided for drug delivery development, and the application prospect is wide. The urgent demand of the hypoxia solid tumor on efficient and diverse ferroptosis treatment strategies on preparations in clinic is met.
Owner:SHENYANG PHARMA UNIV

Silybin mixed micelle injection as well as preparation method and application thereof

The invention provides a silibinin mixed micelle injection as well as a preparation method and application thereof, and belongs to the technical field of pharmaceutical preparations. The cholate / lecithin mixed micelle system constructed by adopting specific cholic acid and phospholipid has good stability, can be well compatible with the silibinin so as to well encapsulate the silibinin, can obviously improve the solubility of the silibinin, has higher safety under the condition of ensuring the stability of the silibinin, and can be used for preparing a medicine for treating the silibinin. Therefore, the bioavailability of the silibinin is greatly improved. According to the invention, a shearing dispersion method is adopted to prepare the mixed micelles, and the mixed micelles with high drug loading capacity, clarification and good stability for silibinin are formed by destroying and shearing the raw and auxiliary materials in a molecular level, so that the mixed micelles have better physical and chemical stability, the drug quality is easier to control, the process is more simplified, the clinical medication is safer and the cost is lower; and the accessibility of the medicine is improved.
Owner:AIWEITUO (JIANGSU) PHARM TECH CO LTD +1

Adriamycin-tetravalent platinum drug-norcantharidin three-drug combined nano-drug as well as preparation method and application thereof

The invention discloses an adriamycin-tetravalent platinum drug-norcantharidin three-drug combined nano-drug as well as a preparation method and application thereof, and belongs to the technical field of medical materials. A tetravalent platinum drug modified by demethylated cantharidin and adriamycin are used as raw materials, a novel nano-drug is constructed through Cu < 2 + > coordination, and then the nano-drug combining adriamycin, the tetravalent platinum drug and demethylated cantharidin is prepared by polymerizing polydopamine with a mild photo-thermal effect. The polymer has the capacity of controllably releasing drugs under acidity and reduction, can realize photo-thermal conversion under laser irradiation to generate a mild photo-thermal effect, has a better tumor cell killing effect, has the capacity of consuming glutathione and generating hydroxyl radicals, can enter cancer cells in an endocytosis mode and release DOX, and can be used for killing tumor cells. And a new thought is provided for multi-drug combination and chemotherapy-chemokinetics therapy-photothermal therapy multi-mode combined therapy.
Owner:QILU UNIVERSITY OF TECHNOLOGY (SHANDONG ACADEMY OF SCIENCES)

Asparagine endopeptidase inhibitor neuronal targeting liposome and preparation method thereof

The invention relates to an asparagine endopeptidase inhibitor neuronal targeting liposome and a preparation method thereof. The liposome comprises the following components: lecithin, cholesterol, phospholipid polyethylene glycol polypeptide, a fluorescent dye and an asparagine endopeptidase inhibitor. The preparation method has relatively good drug loading capacity and entrapment efficiency; after being atomized and dosed through a nose, the nebulizer can smoothly enter the brain of a mouse through a blood brain barrier to be distributed, and has good biocompatibility; according to the invention, DNA damage and ROS reaction of irradiated brain neurons and glial cells can be reduced, and the research and development value and important academic significance of the liposome for assisting in improving radiation brain injury are revealed.
Owner:RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Drug sustained release microsphere for injection and preparation method thereof

The invention relates to a drug sustained release microsphere for injection and a preparation method thereof. According to the preparation, the medicine can be continuously released for four weeks to six weeks, and the preparation process of the preparation is relatively simple, so that the preparation is relatively simple and feasible in industrial production and has better universality. The preparation is a sustained-release microsphere injection, and the prepared microspheres are narrower in particle size distribution, high in encapsulation efficiency and low in burst release rate. According to the preparation method, by adjusting the proportion of the active pharmaceutical ingredients in the oil phase to the biocompatible high polymer material, the proportion of the mass of the organic solvent to the volume of the external water phase and the dosage of the surfactant, the preparation can be matched with the properties of the active pharmaceutical ingredients to achieve the effect of sustained release.
Owner:ZHUHAI HUAHAIKANG MEDICAL TECH CO LTD

Antibacterial catheter and preparation method thereof

ActiveCN119113230Agood swelling propertiesAdjustable and enhanced swellingCatheterPharmaceutical drugCatheter
The invention provides an antibacterial catheter and a preparation method thereof. The antibacterial catheter comprises a catheter main body, the material of the catheter main body comprises silica gel, a solvent used in the preparation process of the antibacterial catheter comprises hexafluoroisopropanol, the catheter main body is swelled by using the solvent, and an antibacterial agent is dispersed in the catheter main body. The hexafluoroisopropanol has a good swelling effect on the catheter main body, so that the antibacterial agent can be well loaded on the catheter main body. And the preparation process is simple, so that when the antibacterial agent is dispersed in the catheter main body, additional basifier, penetrant or drug solubilizer (such as NaOH) and the like are not needed, and subsequent treatment such as heating or high-pressure sterilization and the like is also not needed.
Owner:GUANGZHOU MIROSIGHT MEDICAL TECHNOLOGY CO LTD

Targeted mPDA / MSNs nano-drug delivery carrier for inducing ferroptosis as well as preparation method and application of targeted mPDA / MSNs nano-drug delivery carrier

The invention discloses a ferroptosis-inducing targeted mPDA / MSNs nano-drug delivery carrier as well as a preparation method and application thereof, and relates to the technical field of preparation of targeted nano-delivery carriers. The preparation method comprises the following steps: firstly, connecting and modifying-NH2 to the surfaces of MSNs to obtain amino modified MSNs-NH2; the preparation method comprises the following steps: coating with mPDA to obtain mPDA / MSNs-NH2, and reacting with ferrous lactate to obtain Fe < 2 + >-mPDA / MSNs-NH2; the final carrier RGD-Fe2 +-mPDA / MSNs-NH2 is prepared by coupling an RGD targeting peptide, the particle size is uniform, the physicochemical property is stable, the ATRA and DOX encapsulation efficiency and the drug loading capacity are high, the drug can be responsively released in a simulated tumor microenvironment, a drug-loaded sample RFP / MN atD / A can deliver a drug into tumor cells in a targeting manner, ferroptosis can be rapidly induced, and the tumor cells can be effectively killed through synergistic chemotherapy.
Owner:HENAN UNIVERSITY OF TECHNOLOGY

Pramipexole oral soluble film composition as well as preparation method and application thereof

The invention provides a pramipexole oral soluble film composition as well as a preparation method and application thereof. The invention provides a pramipexole oral soluble film composition. The pramipexole oral soluble film composition comprises an active medicine, a film-forming material, a plasticizer and a flavoring agent, the active drug is a hydrochloride of S-2-amino-4, 5, 6, 7-tetrahydro-6-(propylamino)-benzothiazole as shown in a formula I and / or other pharmaceutically acceptable salt forms of the hydrochloride of S-2-amino-4, 5, 6, 7-tetrahydro-6-(propylamino)-benzothiazole as shown in the formula I. The pramipexole oral soluble film composition has the advantages that the pramipexole oral soluble film composition is thin in thickness, fast in disintegration, free of grit feeling after being dissolved in the oral cavity, capable of improving the taste of a medicine and improving the compliance of a patient, capable of being instantly dissolved in the oral cavity without drinking water, fast in oral absorption speed, uniform in film appearance, high in tensile capacity, good in flexibility and long in service life. Meanwhile, the raw materials are easy to obtain, the process is simple, the operation is simple and convenient, the drug loading capacity is high, the drug content uniformity is good, and the preparation method is suitable for industrial production. # imgabs0 #
Owner:SHANGHAI BOCIMED PHARMA CO LTD +1

Ultrasonic responsive antibacterial microbubble and preparation method thereof

The invention discloses an ultrasonic responsive antibacterial microbubble and a preparation method thereof. The preparation method comprises the following steps: (1) preparing an mPEG-b-(PCL-co-PLA) copolymer; (2) preparing an organic phase; (3) preparing an inner water phase; (4) preparing an external water phase; (5) mixing the internal water phase into the organic phase to prepare a W / O primary emulsion; (6) dispersing the W / O primary emulsion into an external water phase under a mechanical stirring condition to obtain W / O / W multiple emulsion, and preparing antibacterial microbubbles; and (7) injecting C3F8 gas into the antibacterial microbubbles to obtain the ultrasonic responsive antibacterial microbubbles. The ultrasonic-responsive antibacterial microbubbles prepared by the method have good structural stability, can be kept stable in an in-vivo environment and ensure that drugs can be effectively released when needed, and the addition of tricalcium phosphate enhances the responsiveness of the antibacterial microbubbles under the action of ultrasonic waves and improves the release efficiency of the drugs; meanwhile, the responsive antibacterial microbubbles prepared by the method disclosed by the invention also have good biocompatibility and safety.
Owner:CHARACTERISTIC MEDICAL CENT OF THE CHINESE PEOPLES LIBERATION ARMY STRATEGIC SUPPORT FORCES

Trans-sclera continuous drug delivery device for eye disease treatment and preparation method of trans-sclera continuous drug delivery device

The invention discloses a transsclera continuous drug delivery device for eye disease treatment and a preparation method thereof. The device comprises an arc body, a wing-shaped fixing plate and a fixing band. A groove is formed in the bottom surface of the arc body; the two wing-shaped fixing plates are symmetrically arranged on the two sides of the arc body. The two wing-shaped fixing plates are respectively accommodated under the abdomen of the external rectus and under the abdomen of the lower rectus; the fixing belts are fixedly connected to the bottom face of the arc body, and gaps are formed between the fixing belts and the inner wall of the groove and used for storing medicine films; the ends, away from the arc body, of the two-wing-shaped fixing plates are spaced, and the arc body and the two-wing-shaped fixing plates are integrally in a C shape. The eye drops can be well attached to eyeballs, compression on the eyeballs is reduced, free rotation of the eyeballs is not affected, wearing comfort and medicine bioavailability are improved, medicine components are prevented from leaking to the keratoconjunctival surface and fascia tissue, medicine is prevented from going into blood pressure circulation through conjunctival blood vessels and lymphatic vessels, and the risk of side effects of the whole body is reduced; and toxicity and adverse reactions are reduced.
Owner:AIER EYE HOSPITAL GRP CO LTD CHANGSHA AIER EYE HOSPITAL

Slow-release sodium sarcosinate and preparation method thereof

The invention relates to the technical field of sodium sarcosine, in particular to slow-release sodium sarcosine and a preparation method thereof. The slow-release sodium sarcosine is prepared from the following raw materials in parts by weight: 70 to 80 parts of sodium sarcosine aqueous solution, 5 to 10 parts of acrylic acid, 5 to 10 parts of acrylamide, 3 to 5 parts of hydrotropy monomer A, 0.5 to 1 part of hydrotropy monomer B, 0.05 to 0.15 part of cross-linking agent and 0.05 to 0.15 part of initiator, and the hydrotropy monomer B is a mixture of diallyl dimethyl ammonium chloride and methacryloyloxyethyl trimethyl ammonium chloride. The sustained-release sodium sarcosinate disclosed by the invention has relatively high drug loading capacity and encapsulation efficiency, does not generate a burst release phenomenon, and can act for a relatively long time in vivo, so that the benefits of the sustained-release sodium sarcosinate are better exerted, the intake frequency is reduced, and the sustained-release sodium sarcosinate has a wide application prospect.
Owner:FUSHUN SHUNTE CHEM

Ultrasonic activation type carrier-free nano-drug as well as preparation method and application thereof

The invention discloses an ultrasonic activation type carrier-free nano-drug as well as a preparation method and application thereof, and belongs to the technical field of biological medicines. The nano-drug is formed by self-assembly of a sound-sensitive agent and a chemotherapy prodrug, the sound-sensitive agent is an organic small molecule capable of generating ROS through ultrasonic irradiation, and the chemotherapy prodrug is an ROS response type SN38 prodrug. Only after the carrier-free nano-drug provided by the invention is subjected to ultrasonic irradiation, the sound-sensitive agent can generate active oxygen, further activate the chemotherapeutic prodrug and release the active substance of the chemotherapeutic drug to induce tumor cell apoptosis, the tumor treatment effect is improved in an ultrasonic triggering manner, and toxic and side effects caused by non-specific distribution of the chemotherapeutic drug are avoided. The preparation method disclosed by the invention is simple and mild in reaction condition, and has great potential in the fields of preparation and application of tumor drugs.
Owner:ZHEJIANG UNIV

Ternary carrier-free nanoparticle as well as preparation method and application thereof

The invention discloses a ternary carrier-free nanoparticle as well as a preparation method and application thereof. The ternary carrier-free nanoparticles comprise nanoparticles which are formed by the chlorine e6, the lonidamine and the RG108 through an intermolecular interaction force. The nanoparticles can improve effective absorption and accumulation of drugs in tumors, can induce tumor specific pyroptosis and immunogenic effect under laser irradiation, and can promote maturation of antigen presenting cells and recruitment and activation of cytotoxic T lymphocytes, thereby starting adaptive anti-tumor immunity.
Owner:DONGGUAN PEOPLES HOSPITAL